Preclinical drug development in the antiepileptic drug development program. A cooperative effort of government and industry.
Kupferberg
H J
HJ
Preclinical Pharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D004353:Drug Evaluation, Preclinical / Q000379:methods; D006076:Government; D006801:Humans; D014481:United States
D000927:Anticonvulsants